EPISODE · Dec 22, 2023 · 27 MIN
The Challenges of Rare Neurological Disease Drug Development
from Citeline Podcasts · host Norstella
In this episode, In Vivo speaks to Bruce Leuchter, CEO of Neurvati Neurosciences, about ways clinical drug development in rare neurologic diseases is being held back and what can be done to make the process more efficient and successful.
Embed this episode
NOW PLAYING
The Challenges of Rare Neurological Disease Drug Development
0:00
27:55
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 27 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on December 22, 2023.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!